Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK10 | P53779 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 3/20 | 0.39 |
| ▸ | PTGES2 | Q9H7Z7 | 2/20 | 0.38 |
| ▸ | TNNI3K | Q59H18 | 1/20 | 0.37 |
| ▸ | XPO1 | O14980 | 1/20 | 0.37 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.36 |
| ▸ | TEAD1 | P28347 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29704110 | 1.00 | MAPK10 (0.41) | MAPK10GAAKDM4EPOLBPTGES2 | |
| SCHEMBL29473390 | 0.79 | CCR6 (0.43) | MAPK10GAAKDM4EPTGES2TNNI3K | |
| SCHEMBL29704095 | 0.77 | GAA (0.36) | MAPK10GAAKDM4EPOLBPTGES2 | |
| SCHEMBL31331958 | 0.77 | TEAD1 (0.43) | MAPK10GAAKDM4EPTGES2TNNI3K | |
| SCHEMBL26669264 | 0.76 | GAA (0.44) | MAPK10GAAKDM4EPOLBTNNI3K | |
| SCHEMBL30194891 | 0.76 | PTGES2 (0.54) | MAPK10GAAKDM4EPTGES2TNNI3K | |
| SCHEMBL26669276 | 0.75 | GAA (0.40) | MAPK10GAAKDM4EPOLBTNNI3K | |
| SCHEMBL22718342 | 0.74 | KDM4E (0.54) | MAPK10GAAKDM4EPOLBTNNI3K | |
| SCHEMBL29704094 | 0.74 | KDM4E (0.54) | MAPK10GAAKDM4EPOLBTNNI3K | |
| SCHEMBL24501947 | 0.71 | KDM4E (0.55) | MAPK10GAAKDM4ETNNI3KTEAD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4281073-A1 | COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER | Ikena Oncology, Inc. (US) | 2023-11-29 | — | — | EP | disclosed |
| WO-2022159986-A1 | COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER | Ikena Oncology, Inc. (US) | 2022-07-28 | — | — | WO | disclosed |